Private Label
Tranexamic Acid Serum Manufacturer
Private Label
Tranexamic Acid Serum Manufacturer
Product Description
Private Label Tranexamic Acid Serum Manufacturer
DEL'LA SOFT is a private label tranexamic acid serum manufacturer in Turkey, supporting skincare brands, distributors and beauty businesses with OEM/ODM serum development and production. Create a serum under your own brand designed to address the appearance of uneven skin tone and dark spots through a formulation tailored to your product brief and target market.
Private label development can cover formulation planning, packaging selection, product presentation and agreed cosmetic documentation support. The standard starting minimum order quantity is 500 units per SKU for applicable projects, subject to formulation and packaging requirements.
Private Label Tranexamic Acid Serum Specifications
| Specification | Details |
|---|---|
| Product | Tranexamic Acid Facial Serum |
| Manufacturing model | Private Label, OEM and ODM |
| MOQ | From 500 units per SKU, subject to project requirements |
| Formulation | Customised according to the approved project brief |
| Product positioning | Uneven skin tone and the appearance of dark spots |
| Packaging | Compatible serum bottles and other available formats |
| Production lead time | Typically 4–5 weeks after formula and packaging approval, subject to project confirmation |
| Quality standards | ISO 22716 GMP and ISO 9001 |
| Market support | EU and UK cosmetic documentation support within the agreed project scope |
Custom Tranexamic Acid Serum Formulation
Tranexamic acid is used in cosmetic skincare formulations designed to improve the appearance of uneven skin tone and visible discoloration. Its suitability, concentration and compatibility with other ingredients must be assessed as part of the complete formula rather than selected in isolation.
DEL'LA SOFT evaluates private label serum concepts according to the intended product positioning, target audience, packaging and destination market.
Serum for Uneven Skin Tone
A tranexamic acid serum can be developed for brands targeting the appearance of uneven skin tone and dark spots. The formulation brief should establish the intended cosmetic benefits, texture, absorption profile and preferred finish.
Product claims must be appropriate for a cosmetic product and supported by evidence relevant to the finished formulation. Avoid presenting the serum as a treatment for melasma or other medical skin conditions.
Formulation Compatibility and Texture
A successful serum requires more than the selection of a featured ingredient. The formulation should be assessed for ingredient compatibility, pH where relevant, appearance, texture, stability and compatibility with the selected packaging.
Depending on technical feasibility, a project brief may also consider supporting skin-conditioning or hydrating ingredients. Any combination must be assessed in the context of the complete formula, including its stability and intended use.
Concentration and Product Claims
The appropriate tranexamic acid concentration should be established during formulation development based on the intended product, ingredient specifications, technical feasibility and applicable market requirements.
A specific concentration or performance outcome should not be promised before the formula has been developed and assessed. Claims about visible results should accurately reflect the evidence available for the finished product.
Packaging Options for Tranexamic Acid Serum
Packaging affects the product's appearance, dispensing experience and compatibility with the formula. Available options depend on supplier availability, filling requirements and the approved product specifications.
-
Serum bottles: Select a format suited to the intended product presentation and dispensing method.
-
Dropper closures: Consider where appropriate for the formula and intended consumer use.
-
Pump or airless formats: Assess where compatible with the formulation and available packaging components.
-
Brand presentation: Coordinate bottle colour, closure, label and secondary packaging according to the project brief.
The final packaging should be evaluated with the approved formula for compatibility, dispensing performance, leakage and product stability. Packaging suitability should not be assumed solely from its appearance.
Quality Standards and EU/UK Cosmetic Support
DEL'LA SOFT operates with ISO 22716 GMP and ISO 9001 quality standards. Product specifications, the approved formula, packaging components and applicable quality requirements should be agreed before production.
For brands planning to sell in the European Union or United Kingdom, documentation support can be discussed according to the agreed project scope. Depending on the destination market and project arrangements, this may include support relating to:
-
EU Cosmetics Regulation (EC) No 1223/2009.
-
Product Information File (PIF) and Cosmetic Product Safety Report (CPSR) coordination.
-
EU Cosmetic Products Notification Portal (CPNP) requirements.
-
UK Submit Cosmetic Product Notifications (SCPN) requirements.
-
Ingredient information, labelling and cosmetic product claims.
EU and UK requirements are not identical. The applicable Responsible Person arrangements, safety assessment, notifications and labelling obligations must be addressed for the intended market. The exact scope of DEL'LA SOFT's documentation support should be confirmed for each project.
MOQ and Production Timeline
The standard starting MOQ for applicable private label tranexamic acid serum projects is 500 units per SKU. The confirmed minimum depends on the formulation, packaging components, order specifications and requested customisation.
Production typically takes 4–5 weeks after formula and packaging approval, subject to project confirmation. Formulation development, sample approval, packaging sourcing, stability work or additional testing may extend the overall launch schedule.
For a project quotation, provide your target quantity, intended markets, preferred serum packaging and product concept. If you have a specific tranexamic acid concentration or supporting ingredients in mind, include these as preferences for technical review rather than assuming they are already confirmed.
Private Label Tranexamic Acid Serum Manufacturing Process
-
Project brief: Define the target market, intended cosmetic benefits, target quantity and brand positioning.
-
Formulation planning: Assess the tranexamic acid concept, ingredient preferences and technical requirements.
-
Sampling and approval: Review the proposed formula's appearance, texture and application experience.
-
Packaging selection: Confirm the compatible serum bottle, dispensing system, label and secondary packaging.
-
Production and quality control: Manufacture, fill and pack the approved product according to the agreed specifications and quality procedures.
-
Documentation and shipment handover: Complete the agreed production documentation and prepare the order for handover under the confirmed shipping terms.
Frequently Asked Questions
1. What is the MOQ for private label tranexamic acid serum?
The standard starting MOQ is 500 units per SKU for applicable projects. The final minimum depends on formulation, packaging and order specifications.
2. Can I request a custom tranexamic acid serum formula?
Yes, your product brief can be assessed for a customised formulation. The proposed ingredient combination, concentration, texture and packaging must be technically feasible and approved before production.
3. Can tranexamic acid serum be positioned for dark spots?
It can be positioned around improving the appearance of uneven skin tone and visible discoloration, provided the claims are appropriate for the finished cosmetic product and supported by suitable evidence. Medical treatment claims should be avoided.
4. Can I combine tranexamic acid with other skincare ingredients?
Potential combinations can be evaluated during formulation development. Compatibility depends on the ingredients, their specifications, the complete formula and the intended product characteristics; combinations should not be promised before technical assessment.
5. What packaging is available for private label tranexamic acid serum?
Serum bottles, dropper closures and pump or airless formats may be considered, subject to availability and formula compatibility. The final packaging choice should be confirmed through the project review.
6. How long does manufacturing take?
Production typically takes 4–5 weeks after formula and packaging approval, subject to confirmation. Development, sampling, packaging procurement and additional testing may affect the overall timeline.
7. Can you support EU and UK market requirements?
Documentation support can be discussed within the agreed project scope, including relevant EU and UK cosmetic requirements. The required safety assessment, Responsible Person arrangements, notifications and labelling depend on the destination market.
Develop Your Private Label Tranexamic Acid Serum
Whether you are launching a new skincare brand or expanding an existing range, DEL'LA SOFT can assess your private label tranexamic acid serum project from formulation planning and packaging selection to manufacturing and agreed EU/UK documentation support. Share your product concept, target quantity, packaging preferences and intended markets to establish the appropriate technical and commercial scope.
Contact DEL'LA SOFT via WhatsApp, phone or email to discuss your private label tranexamic acid serum project and request a manufacturing quotation.
